NCT00700336 Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II) Status COMPLETED Phase PHASE1/PHASE2
NCT00697437 Effect of Ketoconazole Inhibition of CYP3A on Urinary Excretion of Docetaxel Status COMPLETED Phase PHASE2
NCT00688116 Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors Status UNKNOWN Phase PHASE1
NCT00687934 Study of STA-9090, Administered Once-Weekly in Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT00674947 A Phase I Study of BIIB015 in Relapsed/Refractory Solid Tumors Status COMPLETED Phase PHASE1
NCT00667147 Phase I Abraxane Weekly and Three Weekly Schedule With Vandetanib Status COMPLETED Phase PHASE1
NCT00661414 Safety Study of ASONEP (Sonepcizumab/LT1009) to Treat Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00660426 Study Of Advanced Gastrointestinal Malignancies And Other Solid Tumors Status COMPLETED Phase PHASE1
NCT00658970 Evaluation of KX2-391 in Patients With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT00652626 Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function Status COMPLETED Phase PHASE1
NCT00648648 A Dose Escalation Study of Adavosertib (MK-1775) in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001) Status COMPLETED Phase PHASE1
NCT00636545 Genasense as a 2-hour Intravenous Infusion in Subjects With Solid Tumors Status COMPLETED Phase PHASE1
NCT00635596 Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer Status COMPLETED Phase PHASE1
NCT00635284 ABI-009 Trial in Patients With Advanced Non-hematologic Malignancies Status COMPLETED Phase PHASE1
NCT00634010 Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain Status TERMINATED Phase PHASE3
NCT00629200 Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT00628732 A Pharmacokinetic Study of Oral Cyclophosphamide and Topotecan in Children With Recurrent Solid Tumors Status COMPLETED Phase PHASE2